Please use this identifier to cite or link to this item: https://scholarhub.balamand.edu.lb/handle/uob/6589
Title: Epidemiology and Outcomes of Glomerular Diseases in Low- and Middle-Income Countries
Authors: Ekrikpo, Udeme
Obiagwu, Patience
Chika-Onu, Ugochi
Yadla, Manjusha
Karam, Sabine
Tannor, Elliot K
Bello, Aminu K
Okpechi, Ikechi G
Affiliations: Faculty of Medicine 
Keywords: IgA nephropathy
LMICs
Minimal change disease
Focal segmental glomerulosclerosis
Glomerulonephritis
Kidney biopsy
Lupus nephritis
Membranous nephropathy
Issue Date: 2022-09-01
Publisher: National Library of Medicine
Part of: Seminars in Nephrology
Volume: 42
Issue: 5
Abstract: 
Glomerular diseases account for a significant proportion of chronic kidney disease in low-income and middle-income countries (LMICs). The epidemiology of glomerulonephritis is characterized inadequately in LMICs, largely owing to unavailable nephropathology services or uncertainty of the safety of the kidney biopsy procedure. In contrast to high-income countries where IgA nephropathy is the dominant primary glomerular disease, focal segmental glomerulosclerosis is common in large populations across Latin America, Africa, Middle East, and South East Asia, while IgA nephropathy is common in Chinese populations. Despite having a high prevalence of known genetic and viral risk factors that trigger focal segmental glomerulosclerosis, membranoproliferative glomerulonephritis also is common in adults and children in some African countries. Treatment of glomerular diseases in adults and children in LMICs largely is dependent on corticosteroids in combination with other immunosuppressive therapy, which often is cyclophosphamide because of its ready availability and low cost of treatment, despite significant adverse effects. Partial and/or complete remission status reported from studies of glomerular disease subtypes vary across LMIC regions, with high rates of kidney failure, mortality, and disease, and treatment complications often reported. Improving the availability of nephropathology services and ensuring availability of specific therapies are key measures to improving glomerular disease outcomes in LMICs.
URI: https://scholarhub.balamand.edu.lb/handle/uob/6589
ISSN: 02709295
DOI: 10.1016/j.semnephrol.2023.151316
Type: Journal Article
Appears in Collections:Faculty of Medicine

Show full item record

SCOPUSTM   
Citations

2
checked on Apr 13, 2024

Record view(s)

42
checked on Apr 17, 2024

Google ScholarTM

Check

Dimensions Altmetric

Dimensions Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.